| Proceedings From the Global Cardio-Oncology Summit The Top 10 Priorities to Actualize for CardioOncology |
14 |
| Osimertinib-Induced Cardiotoxicity A Retrospective Review of the FDA Adverse Events Reporting System (FAERS) |
10 |
| Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer |
9 |
| Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor |
8 |
| Increased Cancer Prevalence in Peripartum Cardiomyopathy |
8 |
| Immune Checkpoint Inhibitor-Related Adverse Cardiovascular Events in Patients With Lung Cancer |
7 |
| Efficacy of Neurohormonal Therapies in Preventing Cardiotoxicity in Patients With Cancer Undergoing Chemotherapy |
7 |
| Safety of Continuing Trastuzumab Despite Mild Cardiotoxicity A Phase I Trial |
6 |
| The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity |
6 |
| Hypertension in Cancer Patients and Survivors Epidemiology, Diagnosis, and Management |
6 |
| AL Amyloidosis for the Cardiologist and Oncologist Epidemiology, Diagnosis, and Management |
5 |
| Renin-Angiotensin-Aldosterone System Modulates Blood Pressure Response During Vascular Endothelial Growth Factor Receptor Inhibition |
4 |
| Prokineticin Receptor-1 Signaling Inhibits Dose- and Time-Dependent Anthracycline-Induced Cardiovascular Toxicity Via Myocardial and Vascular Protection |
4 |
| Pre-Diagnosis Exercise and Cardiovascular Events in Primary Breast Cancer Women's Health Initiative |
3 |
| Symptomatic Heart Failure in Acute Leukemia Patients Treated With Anthracyclines |
3 |
| Ischemia and Bleeding in Cancer Patients Undergoing Percutaneous Coronary Intervention |
2 |
| Remote Ischemic Pre-Conditioning Attenuates Adverse Cardiac Remodeling and Mortality Following Doxorubicin Administration in Mice |
2 |
| Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics What Is the Evidence? |
1 |
| Best Practices for Prognostic Evaluation of a Patient With Transthyretin Amyloid Cardiomyopathy |
1 |
| Predictive Value of the Platelet-to-Lymphocyte Ratio in Cancer Patients Undergoing Transcatheter Aortic Valve Replacement |
1 |
